Merck & Co., Inc.

Contact Contact the Merck Patient Assistance Program
PODCAST Podcast
RSS RSS


What Medicines Are Covered

Many Merck products are included in this program. A partial list of Merck medicines provided through the Patient Assistance Program follows. These medicines can only be prescribed by a doctor.


IMPORTANT INFORMATION FOR PATIENTS
If you are a patient and have a question about whether a specific Merck medicine, not listed, is provided through the Patient Assistance Program, please call 1-800-727-5400.

Please discuss the risks and benefits of all medicines with your doctor and take only as prescribed by your doctor.


IMPORTANT INFORMATION FOR HEALTHCARE PROFESSIONALS
If you are a healthcare professional and have a question about whether a specific Merck medicine, not listed, is provided through the Patient Assistance Program, please call 1-800-994-2111.

Before prescribing any Merck product, please read the Prescribing Information.


  • COSOPT® (dorzolamide hydrochloride-timolol maleate ophthalmic solution)
  • COZAAR® (losartan potassium tablets)  
  • HYZAAR® (losartan potassium-hydrochlorothiazide tablets)
  • JANUMETTM  (sitagliptin/metformin HCL) 
  • JANUVIATM (sitagliptin) 
  • MAXALT® (rizatriptan benzoate) Tablets
  • MAXALT-MLT® (rizatriptan benzoate) Orally Disintegrating Tablets
  • SINGULAIR® (montelukast sodium) Tablets and Chewable Tablets
  • TRUSOPT® (dorzolamide hydrochloride ophthalmic solution)

There are separate programs for CANCIDAS® (caspofungin acetate) for Injection, INVANZ®  (ertapenem for injection), PRIMAXIN® (imipenem and cilastatin for injectable suspension), and PRIMAXIN®  (imipenem and cilastatin for injection). For information about these additional programs, please call
1-866-840-5400.

There is a separate Patient Assistance Program for CRIXIVAN® (indinavir sulfate) capsules  and ISENTRESS™ (raltegravir) tablets. For more information about this program, please call 1-800-850-3430.

There is a separate Patient Assistance Program for EMEND® (aprepitant) and ZOLINZATM (vorinostat). For information about this program, please call 1-866-363-6379.


COZAAR and HYZAAR are registered trademarks of E.I. du Pont de Nemours and Company, Wilmington, Delaware, USA. Other products listed are registered trademarks of Merck & Co., Inc.


*Software to view files presented in PDF or SWF format is available at no charge through the Adobe Web site. Get Adobe Reader Get Adobe Flash Player

 

Global Health

Help for patients in the developing world

Unbiased Health Information

For unbiased general health information, visit:
 

 Copyright © 2009 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.  Privacy  Terms of Use  Sitemap